Antifungal benzo[b]thiophene 1,1-dioxide IMPDH inhibitors exhibit pan-assay interference (PAINS) profiles.
暂无分享,去创建一个
B. Kobe | J. Fraser | U. Kappler | M. Cooper | A. Robertson | M. Butler | A. Nouwens | Alberto B. Silva | E. Furlong | Ross D. Blundell | L. Kummari
[1] Jayme L. Dahlin,et al. Assay interference and off-target liabilities of reported histone acetyltransferase inhibitors , 2017, Nature Communications.
[2] J. Perfect. The antifungal pipeline: a reality check , 2017, Nature Reviews Drug Discovery.
[3] Martin Pouliot,et al. Pan Assay Interference Compounds (PAINS) and Other Promiscuous Compounds in Antifungal Research. , 2016, Journal of medicinal chemistry.
[4] Jayme L. Dahlin,et al. Assay Interference by Chemical Reactivity , 2015 .
[5] A. Idnurm,et al. Essential Gene Discovery in the Basidiomycete Cryptococcus neoformans for Antifungal Drug Target Prioritization , 2015, mBio.
[6] D. Hu,et al. Antibacterial activities against rice bacterial leaf blight and tomato bacterial wilt of 2-mercapto-5-substituted-1,3,4-oxadiazole/thiadiazole derivatives. , 2015, Bioorganic & medicinal chemistry letters.
[7] Jayme L. Dahlin,et al. PAINS in the Assay: Chemical Mechanisms of Assay Interference and Promiscuous Enzymatic Inhibition Observed during a Sulfhydryl-Scavenging HTS , 2015, Journal of medicinal chemistry.
[8] R. Hamill. Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity , 2013, Drugs.
[9] A. Bonifaz,et al. Opportunistic yeast infections: candidiasis, cryptococcosis, trichosporonosis and geotrichosis , 2013, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[10] B. Kobe,et al. De novo GTP Biosynthesis Is Critical for Virulence of the Fungal Pathogen Cryptococcus neoformans , 2012, PLoS pathogens.
[11] T. A. Binkowski,et al. Bacillus anthracis inosine 5'-monophosphate dehydrogenase in action: the first bacterial series of structures of phosphate ion-, substrate-, and product-bound complexes. , 2012, Biochemistry.
[12] C. Xue,et al. Molecular mechanisms of cryptococcal meningitis , 2012, Virulence.
[13] L. Hedstrom,et al. Allosteric activation via kinetic control: potassium accelerates a conformational change in IMP dehydrogenase. , 2011, Biochemistry.
[14] B. Kobe,et al. Crystallization and preliminary X-ray analysis of mycophenolic acid-resistant and mycophenolic acid-sensitive forms of IMP dehydrogenase from the human fungal pathogen Cryptococcus. , 2010, Acta crystallographica. Section F, Structural biology and crystallization communications.
[15] Y. Sham,et al. Triazole-linked inhibitors of inosine monophosphate dehydrogenase from human and Mycobacterium tuberculosis. , 2010, Journal of medicinal chemistry.
[16] L. Hedstrom. IMP dehydrogenase: structure, mechanism, and inhibition. , 2009, Chemical reviews.
[17] Sean L Seymour,et al. Nonlinear fitting method for determining local false discovery rates from decoy database searches. , 2008, Journal of proteome research.
[18] A. Verma,et al. A general and efficient CuI/BtH catalyzed coupling of aryl halides with thiols , 2007 .
[19] Sean L Seymour,et al. The Paragon Algorithm, a Next Generation Search Engine That Uses Sequence Temperature Values and Feature Probabilities to Identify Peptides from Tandem Mass Spectra*S , 2007, Molecular & Cellular Proteomics.
[20] M. Ali,et al. Synthesis and Anti Tuberculostatic Activity of Novel 1,3,4‐Oxadiazole Derivatives , 2007 .
[21] J. Heitman,et al. The biology of the Cryptococcus neoformans species complex. , 2006, Annual review of microbiology.
[22] F. Studier,et al. Protein production by auto-induction in high density shaking cultures. , 2005, Protein expression and purification.
[23] Robert A. Larsen,et al. Amphotericin B and Fluconazole, a Potent Combination Therapy for Cryptococcal Meningitis , 2004, Antimicrobial Agents and Chemotherapy.
[24] L. D. Nelson,et al. Triad of acute infusion-related reactions associated with liposomal amphotericin B: analysis of clinical and epidemiological characteristics. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[25] F. Collart,et al. A new vector for high-throughput, ligation-independent cloning encoding a tobacco etch virus protease cleavage site. , 2002, Protein expression and purification.
[26] Thomas D. Y. Chung,et al. A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.
[27] L. Hedstrom,et al. Expression, Purification, and Characterization of Inosine 5′-Monophosphate Dehydrogenase from Borrelia burgdorferi * , 1997, The Journal of Biological Chemistry.
[28] R. Aryan,et al. A Combined Synthetic and DFT Study on the Catalyst-Free and Solvent-Assisted Synthesis of 1,3,4-Oxadiazole-2-thiol Derivatives , 2013 .
[29] R D Appel,et al. Protein identification and analysis tools in the ExPASy server. , 1999, Methods in molecular biology.
[30] Amos Bairoch,et al. Detailed peptide characterization using PEPTIDEMASS – a World‐Wide‐Web‐accessible tool , 1997, Electrophoresis.